AU - Shah, Nikunj AU - Shah, Urmi TI - Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis PT - BRIE DP - 2011 Jul 1 TA - Indian Journal of Ophthalmology PG - 318-319 VI - 59 IP - 4 4099- https://journals.lww.com/ijo/pages/default.aspx/article.asp?issn=0301-4738;year=2011;volume=59;issue=4;spage=318;epage=319;aulast=Shah;type=0 4100- https://journals.lww.com/ijo/pages/default.aspx/article.asp?issn=0301-4738;year=2011;volume=59;issue=4;spage=318;epage=319;aulast=Shah AB - The purpose of the study was to report a case of choroidal neovascularization (CNV) secondary to ocular toxoplasmosis in an 18-year-old female patient. She was treated with a single intravitreal injection of ranibizumab. The CNV resolved as confirmed by fluorescein angiography and optical coherence tomography (OCT). The visual acuity improved to 20/30, which was maintained till the last follow-up visit at two years, without requisition of a repeat injection.